Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy
Conditions: Oncology; Breast Cancer; Chemotherapy-induced Nausea and Vomiting Interventions: Drug: Pantoprazole 40mg; Drug: Placebo Sponsor: University of Auckland, New Zealand Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | New Zealand Health | Pantoprazole | Protonix | Research